A Study in Children and Young People With Migraine to Learn What the Body Does to Eptinezumab

Status:
Recruiting

Trial end date:
2023-03-31

Target enrollment:

Participant gender:

The purpose of the study is to investigate how the body absorbs, distributes, and get rid of eptinezumab when given directly into a vein.

Phase 1

H. Lundbeck A/S